Abacept treatment for patients with early active primary Sjögren's syndrome: OPEN-LABEL EXTENSION PHASE OF A RANDOMIZED CONTROLLED PHASE III TRIAL

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)102-102
Number of pages1
JournalAnnals of the Rheumatic Diseases
Volume79
DOIs
Publication statusPublished - Jun-2020
EventAnnual European Congress of Rheumatology (EULAR) -
Duration: 3-Jun-2020 → …

Cite this